The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research organization dedicated to assessing the value of healthcare interventions, including diagnostics, devices, digital therapeutics and prescription drugs. Although ICER’s assessments do not represent a mandate for product…
Improving partnerships is a crucial aspect of successful organizations. However, many companies face challenges in aligning their Commercial Operations and Information Technology teams. These conflicts often lead to inefficiencies in processes, resources and functionality, which ultimately impact the overall capabilities…
The “molecular optimizer” archetype is a strategy utilized by first-launch companies to optimize existing molecules when developing their first product. Companies using this approach tend to be small and emerging biotech firms that are seeking a foothold to enter the…
How are Biopharmaceutical organizations evolving to develop capabilities and propel innovation for 2024 and beyond? Executive leaders in Commercial Operations, Medical Affairs and Market Access are focused on making informed decisions to propel the evolution of their organizations in this…
Rare diseases present unique challenges to companies looking to commercialize treatments. Although there is vast potential in rare disease, each space is different and unique. Companies must effectively address challenges around identifying and treating patients—as well as providing long-term support…
Navigating the MarTech Jungle: An Analysis of The Technology Powering 160+ Pharma Brands. In today's hyperconnected digital landscape, the marketing technology (MarTech) space has exploded into a complex ecosystem of over 10,000 potential vendors and services. The sheer volume of…
This advisory brief incorporates learnings from TGaS Advisors’ 2023 Spring Summit, which brought together the industry’s top commercial operations, market access and medical affairs executives to discuss the hottest trends, address concerns and prepare for future challenges. Leaders from more…
As researchers and clients, we deem the insights of Health Care Professionals (HCP) as being crucial to the development of life saving, game-changing therapies. We require highly skilled, disease-conversant moderators who can match medical terms and treatment protocols with the…
For decades, surgical procedures were confined to hospitals where patients would be admitted to the inpatient ward for days, and often weeks, for recovery and monitoring. Increasingly, as technology, technique and safety improved, hospitals began to offer outpatient surgery to…
Patient Journey is a mainstay of pre-launch commercial insights generation, traditionally sitting beside demand estimation, segmentation and other key inputs to commercial decision-making and launch preparation. Historically, Patient Journey has been used to identify leverage points and opportunities to increase…